M-phase inducer phosphatase 3

BE0012951ProteinHumansCDC25C

Functions as a dosage-dependent inducer in mitotic control. It is acted on by 1 drug in DrugBank.

Gene name
CDC25C
UniProtKB entry
P30307Swiss-Prot
Cellular location
Nucleus
Residues / weight
473 residues · 53,364 Da
Also known as
3.1.3.48 · Dual specificity phosphatase Cdc25C

Resolves to

Protein
UniProtP30307UniProt nameMPIP3_HUMAN
Gene
HGNCHGNC:1727NCBI Gene995GeneCardsCDC25C
Pharmacology
KEGGhsa:995
Structure
PDB2OJXPDB3BZIPDB3OP3
Drugs

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
15GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which compounds in development act on M-phase inducer phosphatase 3, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In